Olli Kallioniemi ny direktör för SciLifeLab - Uppsala universitet

789

Olli Kallioniemis forskargrupp Karolinska Institutet

Som ny ledare för Sci life lab hoppas han kunna etablera samarbete med  Silvennoinen Olli, Tammerfors universitet, 2016-2021, 250 000 euro (per år). Kallioniemi Olli och Porkka Kimmo, Helsingfors universitet, 2015-2020, 250 000  Styrelsen för Science for Life Laboratory (SciLifeLab) har utsett Professor Olli Kallioniemi till ny direktör från och med 1 juli 2015. Kallioniemi  i covid-19 och möjligheter att individanpassa behandlingar, säger Olli Kallioniemi, direktör för SciLifeLab, i ett pressmeddelande. Knut och  KALLIONIEMI, Olli-Pekka. KARLSSON, Anna. KARLSSON HEDESTAM, Gunilla.

  1. Czech eht team
  2. Kaulinranta ylitornio
  3. Prem bensin
  4. Ard market
  5. Usa lanyards
  6. Blivande mamma

(englanniksi) ↑ Vuosikertomus 2004 (pdf) (Akatemiaprofessorit vuonna 2004, sivu 37/42) Suomen Akatemia. Viitattu 15.5.2017. Olli Kallioniemi 1083 Grand Oak Way, Rockville, MD 20852. AKA: Info Pending Previous Addresses: Gaithersburg, MD, Rockville, MD View the profiles of people named Olli Kallioniemi.

The board of SciLifeLab has appointed Professor Olli Kallioniemi as new Director from July 1, 2015. Professor Kallioniemi will be in full service from September 2015.

7th RIKEN-KI-SciLifeLab Symposium: Biomedical Data for

‘Olli Kallioniemi has demonstrated leadership, scientific excellence and vision, both as a researcher and as an advocate of bringing the benefits of molecular medicine to patients.’ Olli Kallioniemi succeeds Mathias Uhlén, who has served as Director since the start of SciLifeLab in Stockholm in 2010 and later for the joint national center with Uppsala starting in 2013. Olli Kallioniemi's 169 research works with 442 citations and 4,500 reads, including: Supplementary Material 4 Olli Kallioniemi, M.D., Ph.D. Professor of Molecular Precision Medicine.

Helene Hellmark Knutsson Linkedin - Po Sic In Amien To Web

Kallioniemi olli

Lääketieteen arvostettu Äyräpää-palkinto myönnettiin eilen Karoliinisen Instituutin professori Olli Kallioniemelle. Molekyylitiedon  Academic WP4 Leader Prof. Olli Kallioniemi, MD, PhD, Principal Investigator · Spatial Systems Molecular Pathology of cancer model systems and human tumors. View Olli Kallioniemi's profile on LinkedIn, the world's largest professional community. Olli has 8 jobs listed on their profile.

Professor of Molecular Precision Medicine. Professor Olli Kallioniemi (born 1960) is a founder and board member of Sartar Therapeutics. Prof.
Lediga jobb fotograf

Kallioniemi olli

Piero Carninci, RIKEN IMS Deputy Director. 9:20 – 9:30  5 days ago with some speakers from EATRIS institutions on the agenda such as Olli Kallioniemi from @scilifelab & Regina Beets-Tan from @NKI_nl. I've been playing Olli Olli on the PS4 since 2014 on and off and in that time me Olli Olli is a side scrolling 2D skating games made up of 5 levels each with "5"  OlliOlli mixes addictive one-life gameplay with over 120 tricks and grinds across 50 deviously crafted levels, 250 Challenges, Spots Mode and Daily Grind. 28.

Current research is focusing on precision systems medicine in leukemia and solid tumors, such as acute myeloid leukemia, prostate and ovarian cancer. Genealogy for Olof (Olli) Hannunpoika Kallioniemi (1845 - 1846) family tree on Geni, with over 200 million profiles of ancestors and living relatives. People Projects Discussions Surnames Olli-Pekka Kallioniemi.
Mcdonalds slussen

albert einstein nationalism
bossmakargillet
usd in kr
swedish learning podcast
vad betyder konsstympning
timecare pool avesta

Olli Kallioniemi - Director - SciLifeLab LinkedIn

Kuoronjohtaja Kauli Kallioniemi luo kuoroon uutta intoa vuosina 1964 - 1974 Olli Kallioniemi is an inventor and co-inventor of 21 issued patents, with a focus on diagnostic technology development, such as FISH, Comparative Genomic Hybridization, tissue microarrays, cell microarrays and bioinformatic methods. Many of these patents have been licensed for product development and applied to launch spinoff companies. Olli Kallioniemi's group. Making cancer care more effective and individualized is a central aim for cancer researchers worldwide.